Kaia Health, a German startup claiming to “change how digital therapy is designed, deployed and experienced” has secured a $26 million Series B funding round, as it scales up attempts to manage chronic pain
The Munich-based company was founded by Konstantin Mehl and Manual Thurner, both of whom suffered from back pain. They vowed to make therapeutics for chronic pain—classed as any lasting longer than 12 weeks—cost-effective and digital. The firm launched in 2016, and has an office in New York City.
Its solution tracks motion in 2D to give users feedback on movement using their smartphone. The company says it now has over 400,000 users.
The funding round will help Kaia invest in research and proprietary technology, including a 3D musculoskeletal version of its software. It was led by Optum Ventures, capital300 and Idinvest, with support from Balderton Capital, Heartcore Capital and Symphony Ventures. Kaia is now backed by around $50m in venture funds.